CSX Stock Overview
Engages in the design, manufacture, and sale of respiratory protection products and services for healthcare and industrial markets worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
CleanSpace Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.38 |
| 52 Week High | AU$0.64 |
| 52 Week Low | AU$0.22 |
| Beta | 0.41 |
| 11 Month Change | -22.68% |
| 3 Month Change | 10.29% |
| 1 Year Change | 11.94% |
| 33 Year Change | -73.96% |
| 5 Year Change | n/a |
| Change since IPO | -94.95% |
Recent News & Updates
Lacklustre Performance Is Driving CleanSpace Holdings Limited's (ASX:CSX) 26% Price Drop
Nov 12
CleanSpace Holdings Limited's (ASX:CSX) Shares Bounce 29% But Its Business Still Trails The Industry
Sep 21CleanSpace Holdings (ASX:CSX) Has Debt But No Earnings; Should You Worry?
Aug 29Recent updates
Lacklustre Performance Is Driving CleanSpace Holdings Limited's (ASX:CSX) 26% Price Drop
Nov 12CleanSpace Holdings Limited's (ASX:CSX) Shares Bounce 29% But Its Business Still Trails The Industry
Sep 21CleanSpace Holdings (ASX:CSX) Has Debt But No Earnings; Should You Worry?
Aug 29Does CleanSpace Holdings (ASX:CSX) Have A Healthy Balance Sheet?
Apr 18CleanSpace Holdings (ASX:CSX) Is Achieving High Returns On Its Capital
Nov 29CleanSpace Holdings Limited's (ASX:CSX) Shares Leap 25% Yet They're Still Not Telling The Full Story
Oct 21Some CleanSpace Holdings Limited (ASX:CSX) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 31Should You Be Impressed By CleanSpace Holdings Limited's (ASX:CSX) ROE?
Feb 18
Here's Why We Don't Think CleanSpace Holdings's (ASX:CSX) Statutory Earnings Reflect Its Underlying Earnings Potential
Jan 23Shareholder Returns
| CSX | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 5.6% | 0.5% | 1.5% |
| 1Y | 11.9% | 14.2% | 17.2% |
Return vs Industry: CSX underperformed the Australian Medical Equipment industry which returned 14.2% over the past year.
Return vs Market: CSX underperformed the Australian Market which returned 17.2% over the past year.
Price Volatility
| CSX volatility | |
|---|---|
| CSX Average Weekly Movement | 16.6% |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: CSX's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: CSX's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 55 | Graham McLean | www.cleanspacetechnology.com |
CleanSpace Holdings Limited engages in the design, manufacture, and sale of respiratory protection products and services for healthcare and industrial markets worldwide. It offers CleanSpace HALO, an elevated level of respiratory protection in healthcare environment; CleanSpace CST PRO, a technology that keeps protected and connected; CleanSpace CST ULTRA, a powered air purifying respirator (PAPR) that provides protection reporting for enhanced safety compliance; CleanSpace EX, an PAPR for explosive atmospheres; and CleanSpace Work, an industrial PAPR for high dust environments. The company also provides accessories and consumable products comprising masks, filters, and docking stations.
CleanSpace Holdings Limited Fundamentals Summary
| CSX fundamental statistics | |
|---|---|
| Market cap | AU$29.08m |
| Earnings (TTM) | -AU$3.13m |
| Revenue (TTM) | AU$15.72m |
1.8x
P/S Ratio-9.3x
P/E RatioIs CSX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CSX income statement (TTM) | |
|---|---|
| Revenue | AU$15.72m |
| Cost of Revenue | AU$4.36m |
| Gross Profit | AU$11.36m |
| Other Expenses | AU$14.49m |
| Earnings | -AU$3.13m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.04 |
| Gross Margin | 72.25% |
| Net Profit Margin | -19.89% |
| Debt/Equity Ratio | 14.5% |
How did CSX perform over the long term?
See historical performance and comparison